硕世生物
(688399)
| 流通市值：43.59亿 | | | 总市值：43.59亿 |
| 流通股本：5862.00万 | | | 总股本：5862.00万 |
| 报告期 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 2,293,637,428.8 | 1,769,363,902.73 | 1,693,020,281.03 | 2,192,901,617.18 |
| 应收票据及应收账款 | 75,306,413.86 | 108,714,894.8 | 254,034,250.57 | 384,000,926.3 |
| 其中：应收票据 | 1,263,808.8 | - | 1,055,077.08 | 39,656,376.46 |
| 应收账款 | 74,042,605.06 | 108,714,894.8 | 252,979,173.49 | 344,344,549.84 |
| 预付款项 | 16,314,165.03 | 16,997,270.68 | 28,519,708.95 | 24,431,347.56 |
| 其他应收款合计 | 6,824,761.01 | 7,187,055.58 | 8,800,102.12 | 44,539,173.91 |
| 存货 | 104,248,482.78 | 93,859,936.04 | 177,750,198.66 | 229,750,513.74 |
| 其他流动资产 | 18,132,324.6 | 18,841,187.66 | 21,724,656.68 | 22,233,761.78 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 2,854,816,048.3 | 2,709,774,293.97 | 3,035,733,567.88 | 3,128,600,118.26 |
| 非流动资产: | | | | |
| 长期股权投资 | 111,795,746 | 112,642,154.12 | 113,741,656.72 | 114,088,369.26 |
| 其他非流动金融资产 | 302,797,944.92 | 303,832,855.42 | 244,454,658.97 | 172,279,321.25 |
| 固定资产 | 586,931,591.59 | 595,806,182.99 | 678,765,898.64 | 690,070,725.23 |
| 在建工程 | 2,061,518 | 1,532,678 | 17,539,411.64 | 17,328,279.13 |
| 使用权资产 | 14,225,449.87 | 17,274,551.6 | 36,518,089.16 | 39,606,309.21 |
| 无形资产 | 29,328,043.4 | 29,884,997.83 | 26,526,102.84 | 26,791,646.06 |
| 长期待摊费用 | 50,654,332.97 | 55,119,449.48 | 47,908,591.36 | 64,447,510.24 |
| 递延所得税资产 | 80,482,714.29 | 80,389,174.86 | 79,377,920.02 | 90,062,429.02 |
| 其他非流动资产 | 157,098 | 157,088 | 5,544,543.15 | 6,429,403.15 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 1,178,434,439.04 | 1,196,639,132.3 | 1,250,376,872.5 | 1,221,103,992.55 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 4,033,250,487.34 | 3,906,413,426.27 | 4,286,110,440.38 | 4,349,704,110.81 |
| 流动负债: | | | | |
| 短期借款 | 310,043,171.55 | 156,942,328.54 | 297,124,834.07 | 190,173,089.84 |
| 应付票据及应付账款 | 42,668,771.42 | 75,024,135.61 | 88,851,802.04 | 136,398,257.39 |
| 应付账款 | 42,668,771.42 | 75,024,135.61 | 88,851,802.04 | 136,398,257.39 |
| 合同负债 | 15,680,512.17 | 14,460,558.98 | 18,677,907.06 | 17,816,994.09 |
| 应付职工薪酬 | 25,713,643.77 | 42,014,938.36 | 24,550,509.86 | 26,545,826.6 |
| 应交税费 | 1,016,473.65 | 2,642,301.78 | 285,056.78 | 1,476,954.37 |
| 其他应付款合计 | 53,899,061.89 | 64,558,437.86 | 68,234,189.37 | 75,197,444.05 |
| 一年内到期的非流动负债 | 5,366,389.84 | 7,817,452.83 | 2,989,400.02 | 12,090,212.3 |
| 其他流动负债 | 439,658.13 | 408,900.42 | 970,994.48 | 961,904.64 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 454,827,682.42 | 363,869,054.38 | 501,684,693.68 | 460,660,683.28 |
| 非流动负债: | | | | |
| 租赁负债 | 8,591,978.21 | 8,695,784.56 | 34,966,383.8 | 29,340,292.52 |
| 长期应付职工薪酬 | 50,000,000 | 50,000,000 | 50,000,000 | 50,000,000 |
| 预计负债 | - | 501,296.75 | - | - |
| 递延收益 | 74,466,934.85 | 78,240,541.93 | 80,915,894.09 | 84,191,503.66 |
| 递延所得税负债 | 192,028.74 | 2,843.54 | 15,642,510.42 | 14,891,036.57 |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 133,250,941.8 | 137,440,466.78 | 181,524,788.31 | 178,422,832.75 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 588,078,624.22 | 501,309,521.16 | 683,209,481.99 | 639,083,516.03 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 58,620,000 | 58,620,000 | 58,620,000 | 58,620,000 |
| 资本公积 | 806,598,045.45 | 806,598,045.45 | 806,598,045.45 | 806,598,045.45 |
| 盈余公积 | 29,310,000 | 29,310,000 | 29,310,000 | 29,310,000 |
| 未分配利润 | 2,550,643,817.67 | 2,510,575,859.66 | 2,708,372,912.94 | 2,816,092,549.33 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 3,445,171,863.12 | 3,405,103,905.11 | 3,602,900,958.39 | 3,710,620,594.78 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 3,445,171,863.12 | 3,405,103,905.11 | 3,602,900,958.39 | 3,710,620,594.78 |
| 负债和股东权益合计 | 4,033,250,487.34 | 3,906,413,426.27 | 4,286,110,440.38 | 4,349,704,110.81 |
| 公告日期 | 2024-04-27 | 2024-04-27 | 2023-10-28 | 2023-08-31 |
| 审计意见(境内) | | 标准无保留意见 | | |